Agios Pharmaceuticals target price raised to $62 from $55
AGIO•H.C. Wainwright raised its target price for Agios Pharmaceuticals to $62 from $55.
Related News
Docebo announces availability of third-quarter 2026 results release
DCBO•
VisionSys AI raises USD 125 million in private placement
VSA•
Emera Q3 adjusted EPS CAD 0.85 vs. IBES estimate CAD 0.91
EMA•
Galiano Gold cites higher gold prices, sales volumes driving Q3 2026 revenue growth
GAU•
Veeva Systems: Needham raises target price to $360 from $310
VEEV•